Compare BIVI & CABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIVI | CABR |
|---|---|---|
| Founded | 2013 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4M | 12.8M |
| IPO Year | 2013 | 2025 |
| Metric | BIVI | CABR |
|---|---|---|
| Price | $1.58 | $1.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.26 | N/A |
| AVG Volume (30 Days) | ★ 156.3K | 42.1K |
| Earning Date | 11-17-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.83 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $4,215.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.82 | $0.71 |
| 52 Week High | $3.79 | $1.84 |
| Indicator | BIVI | CABR |
|---|---|---|
| Relative Strength Index (RSI) | 51.21 | 43.18 |
| Support Level | $1.28 | $0.79 |
| Resistance Level | $1.52 | $1.10 |
| Average True Range (ATR) | 0.11 | 0.16 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 83.78 | 21.22 |
BioVie Inc is a clinical-stage company developing drug therapies for the treatment of neurological and neurodegenerative disorders and liver disease. Its therapeutic areas include Alzheimer's, Parkinson's, Long COVID, Ascites, Longevity, and Epigenetics. In liver disease, its investigational drug candidate BIV201 (continuous infusion terlipressin) was granted FDA Fast Track status and FDA Orphan Drug designation for ascites due to all etiologies except cancer. BIV201 is being evaluated as a treatment option for patients suffering from life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism.
Caring Brands Inc is a wellness consumer products company. It offers several over-the-counter (OTC) and cosmetic consumer products. Its product pipeline includes a diverse products, such as hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, a jellyfish sting protective suncare line, and women's sexual wellness products, catering to diverse health and wellness needs. It operates in a single segment.